PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)

IDX:OBAT Revenue

In the year 2025, PT Brigit Biofarmaka Technologi Tbk had annual revenue of 160.12B IDR with 32.74% growth. PT Brigit Biofarmaka Technologi Tbk had revenue of 45.37B in the quarter ending December 31, 2025, with 45.58% growth.

• Revenue: 160.12B
• Revenue Growth: +32.74%
• P/S Ratio: 0.86
• Revenue / Employee: 7.28B
• Employees: 22
• Market Cap: 138.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	160.12B	39.49B	32.74%
Dec 31, 2024	120.63B	63.70B	111.89%
Dec 31, 2023	56.93B	18.43B	47.89%
Dec 31, 2022	38.50B	642.48M	1.70%
Dec 31, 2021	37.85B	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error